Clinical trial
Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for…
NCT00163293 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00163293 |
|---|---|
| Title | Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 Years) (BY9010/CA-101) |
| Official title | Effect of Low Dose Continuous Treatment With Ciclesonide Over One Year on the Time to First Exacerbation in Children With Mild Asthma Versus Intermittent Treatment for Exacerbations |
| Acronym | POPCICLE |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Ciclesonide, Placebo |
| Enrollment | 240 |
| Start date | Jan 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Apr 1, 2010 |
| First posted | Sep 14, 2005 |
| Last update posted | Apr 26, 2017 |
| Countries | Canada, Hungary, South Africa |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: